title: [New developments in treatment of non-small cell lung cancer].
abstract: In early June the annual meeting of the American Society of Clinical Oncology (ASCO) took place. Several new hypotheses, therapy approaches and clinical studies were presented and intensively discussed. Some new developments in treatment of non-small cell lung cancer will be briefly discussed in this article.
authors.affiliation: LungenClinic, Onkologischer Schwerpunkt, Großhansdorf.
authors.forename: N
authors.initials: N
authors.lastname: Reinmuth
authors.forename: A
authors.initials: A
authors.lastname: Gröschel
authors.forename: M
authors.initials: M
authors.lastname: Reck
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000628:therapy*; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D057054:Molecular Imaging / Q000379:methods; D011799:Quinazolines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride